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Abstract
Background: Maternal nutrition in pregnancy has a crucial impact on the development of the fetus. Dietary trans
fatty acids (tFA) are known to have adverse health effects, especially during pregnancy. However, the distribution
of tFA produced via partial hydrogenation of vegetable oils (mainly elaidic acid; t9) differs compared to ruminant-
derived tFA (mainly vaccenic acid; t11). Recent findings indicate that they may have different impact on human
health.
Therefore, in this study, plasma and erythrocytes of mother-child pairs (n = 55) were sampled to investigate the
distribution of tFA, including individual trans C18:1 fatty acids and conjugated linoleic acids (CLA) in fetal related to
maternal lipids; with additional consideration of maternal dairy fat intake.
Results: Portion of t9 and t11, but also of c9,t11 CLA was higher in maternal than in fetal blood lipids. The portion
of t9 in maternal and fetal lipids differed only slightly. In contrast, the portion of fetal t11 was only half of that in
maternal blood. This led to a fetal t9/t11-index in plasma and erythrocytes being twice as high compared to the
maternal values. A high dairy fat intake resulted in elevated portions of t11 and its Δ9-desaturation product c9,t11
CLA in maternal blood. In contrast, in the respective fetal blood lipids only c9,t11 CLA, but not t11 was increased.
Nevertheless, a positive association between maternal and fetal plasma exists for both t11 and c9,t11 CLA.
Furthermore, in contrast to t9, t11 was not negatively associated with n-3 LC-PUFA in fetal blood lipids.
Conclusions: Fetal blood fatty acid composition essentially depends on and is altered by the maternal fatty acid
supply. However, in addition to dietary factors, other aspects also contribute to the individual fatty acid distribution
(oxidation, conversion, incorporation). The lower portion of fetal t11 compared to maternal t11, possibly results
from Δ9-desaturation to c9,t11 CLA and/or oxidation. Based on the fatty acid distribution, it can be concluded that
t11 differs from t9 regarding its metabolism and their impact on fetal LC-PUFA.
Keywords: trans octadecenoic acids, trans fatty acids, vaccenic acid, elaidic acid, conjugated linoleic acids, omega-3
LC-PUFA, t9/t11-index, fetus, pregnancy, dairy fat
Background
Maternal nutrition may have a crucial impact on the
development of the fetus during pregnancy and even for
the child after birth [1]. Long chain polyunsaturated
f a t t ya c i d s( L C - P U F A ) ,s u c ha sC 2 0 : 4n - 6( a r a c h i d o n i c
acid; AA) and C22:6 n-3 (docosahexaenoic acid; DHA)
are known to be essential for fetal development [2-4].
Moreover, n-3 LC-PUFA have been shown to modulate
the fetal immune system and, thus, possibly decrease
the risk for later atopy development [5]. In contrast,
trans fatty acids (tFA) are considered to enhance the
risk of coronary heart disease [6,7], atopy [8], complica-
tions in pregnancy, e.g. preeclampsia [9] and to impair
fetal development [10]. Extensive data on preferred LC-
PUFA transport from mother to fetus [11,12] as well as
higher LC-PUFA concentrations in fetal than in mater-
nal blood [13-16] have been published over the last few
decades. In contrast, data of fetal blood concentrations
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are scarce. Moreover, in results from studies concerning
tFA, only mean percentage values of total tFA in mater-
nal and/or fetal plasma and erythrocyte lipids have been
reported [13,17-20].
However, since the amount and distribution of indivi-
dual tFA, especially trans C18:1, differs considerably
between industrial and natural (ruminant) tFA sources, a
discussion has arisen regarding the extent to which rumi-
nant tFA raises the risk for cardiovascular diseases in com-
parison to industrial tFA. The latter mainly comprises of
trans-9 C18:1 (elaidic acid; t9) and trans-10 C18:1 [21]. In
contrast, trans-11 C18:1 (vaccenic acid; t11) is the major
trans C18:1 in ruminant tFA principally resulting in a low
t9/t11-index in dairy products (< 1) [22]. The t11 in dairy
fat derives from microbial biohydrogenation of PUFA in
the rumen. Dairy fat also contains CLA, especially c9,t11
CLA produced by rumen microbes and primarily by endo-
genous Δ9-desaturation of t11 by the mammary gland
[23].
It has been argued that in contrast to other trans
C18:1, intake of t1 1i sn o ta s s o c i a t e dw i t hc o r o n a r y
heart disease or inflammation [24]. In fact, t11 may
even impart health benefits due to its function as a
metabolic precursor of c9,t11 CLA. This conversion also
occurs in humans [22,25,26]. Both, t11 and c9,t11 CLA
have been shown to exert anti-inflammatory effects in
allergy models [27,28], and t11 did not negatively alter
inflammatory parameters in humans [29]. High maternal
dairy fat intake led to elevated c9,t11 CLA and t11, thus
decreasing the t9/t11-index in breast milk [30]. These
ruminant fatty acids in breast milk showed protective
effects against the development of atopic manifestation
in infants [31].
To date, no corresponding data concerning individual
trans C18:1 such as t9 and t11 are available for maternal
and the corresponding fetal blood. This study aimed at
characterising the distribution of individual trans iso-
mers of maternal and fetal blood lipids and their asso-
ciation with LC-PUFA in fetal blood lipids. In addition,
the relationship between maternal intake of dairy pro-
ducts and the maternal and fetal blood fatty acid profile
was investigated.
Methods
Subjects and study design
Blood samples from 55 mothers together with cord
blood from their neonates were collected at birth. In
this study, only healthy infants born at term after
uncomplicated pregnancies were included. Mothers with
gestational diabetes or those taking pharmaceuticals
were excluded. After birth, mothers were requested to
answer two questionnaires: one focussing on obstetric
history, lifestyle, and socioeconomic factors and the
other was a food frequency questionnaire (FFQ) dealing
with foods from a variety of groups, such as dairy pro-
ducts, fish, oils, seeds or nuts. The study protocol was
approved by the local ethics committee (Nr. 1345-06/
04). Informed written consent was obtained from all
mothers.
Sample collection and preparation for gas
chromatography
Maternal blood was drawn at birth from a peripheral vein.
Fetal blood was drawn by venipuncture from the placental
portion of the umbilical cord immediately after clamping.
Blood was collected in EDTA-tubes (S-Monovette 9 ml
KE3, Sarstedt). Plasma was separated by centrifugation
(1500 × g, 10 min, 4°C) and erythrocytes were washed
three times with physiological sodium chloride solution.
Plasma and erythrocytes were frozen immediately at -80°C
and stored until lipid extraction.
Lipid extraction and transmethylation
Lipids were extracted from plasma and erythrocytes based
on the method of Bligh and Dyer [32]. Lipid extracts were
transmethylated by using a combination of 0.5 N metha-
nolic sodium hydroxide (Merck) and 10% (w/w, Supelco)
boron trifluoride-methanol (100°C for 5 min each). Subse-
quently, fatty acid methyl esters (FAME) were purified by
thin layer chromatography and dissolved in n-hexane for
analysis [33]. A system of two GC/FID methods was used
t oa n a l y s et h ef u l lf a t t ya c i ds p e c t r u mf r o mC 4t oC 2 6
including CLA (GC-17 V3 Shimadzu; DB-225MS: 60 m, i.
d. 0.25 mm, 0.25 μm film thickness; Agilent Technologies)
as well as cis and trans isomers of C18:1, trans C18:2 and
C18:3 (GC-2010, Shimadzu; CP-select 200 m × 0.25 mm
i.d. with 0.25 μmf i l mt h i c k n e s s ;V a r i a n )[ 2 1 ] .I nb r i e f ,
injector and detector temperatures were maintained at
260°C and 270°C, respectively, with hydrogen as carrier
gas [21]. In total 88 fatty acids were identified and detect-
able trans C18:1 comprise the following isomers: t4, t5, t6/
7/8, t9, t10, t11, t12, t13/14, t15, and t16 C18:1. Further-
more, t9,t12; c9,t12; t9,c12 C18:2; t3,c9,c11 and c8,t10,t12
C18:3, were summarised as total tFA. Fatty acid concen-
trations were expressed as the percentage of the total area
of all FA peaks (% of total FAME).
Data evaluation and statistics
Evaluation of food frequency questionnaires (n = 41)
was carried out using Prodi 5.5 Nutriscience software
(summarized in Table 1). Fourteen questionnaires had
to be excluded due to unreliable data.
Statistical analysis was performed via PASW statistics,
version 17 (SPSS Inc.). To evaluate differences and cor-
relations between maternal and fetal fatty acid composi-
tions, paired student’s t-test was conducted and Pearson
correlation coefficient was calculated. Unpaired t-test
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subgroups of high and low dairy fat intake. Data were
reported as means ± SD. Significance was defined as P ≤
0.05.
Results
Subjects
The mean maternal age at birth was 29.2 years. Infants
had normal birth weight and length (Table 2).
Dietary intake
Mothers reported that they did not essentially change
their dietary habits during pregnancy. In general, they
consumed western-style diets that were predominantly
omnivore. The fat intake (n = 41) averaged 124 g per
day which corresponds to 45% of total energy intake (en
%), with high inter-individual variations (from 55 to 215
g/d; Table 1). Mean dairy fat intake was 36.7 g/d, ran-
ging from 7.29 g/d (2.2 en%) to 82.1 g/d (39.3 en%).
Mothers who reported a high dairy fat intake (> 40 g/d)
tended to have higher energy uptake due to the raised
dietary fat (increased by 1.2 times). In addition, their
dietary intake of saturated and short chain fatty acids
was also 1.3 to 2 times higher (Table 1). Overall, fish
was reportedly consumed less than once a week and n-3
PUFA supplementation (e.g. by fish oil capsules) was
not common (n = 11; 20%). A high dairy fat intake was
not associated with fish oil supplementation and
increased intake of n-3 PUFA-rich foods (e.g., fish, nuts,
and vegetable oils). If fish oil was supplemented, a
higher proportion of n-3 LC-PUFA in maternal lipids
was not observed (data not shown).
Fatty acid profile in maternal and fetal blood lipids
(n = 55)
- Trans fatty acids
The mean total tFA, as well as t9a n dt11 in plasma and
erythrocyte lipids were significantly higher in maternal
compared to fetal lipids (Table 3). However, in both fetal
lipids fractions, t11 levels were half of t9 values leading to
ah i g h e rf e t a lt9/t11-index compared to the maternal
index in both plasma and erythrocytes (Table 3).
Total tFA in maternal plasma (Pmat)c o r r e l a t e dp o s i -
tively with total tFA concentrations in fetal plasma
(Pfet). There was no correlation of t9 between Pmat and
Pfet.O nt h ec o n t r a r y ,t h e r ew a sap o s i t i v ec o r r e l a t i o n
between Pmat and Pfet for t11. In general, no correlation
for total tFA as well as t9a n dt11 was found between
maternal and fetal erythrocytes (Emat,E fet, respectively;
Table 3).
On the other hand, positive correlations were found
within the respective blood fraction between t9a n dt11
(Pmat: r = 0.33, P < 0.05; Pfet: r = 0.39, P < 0.001; Emat:r=
0.12, P = 0.37; Efet: r = 0.89, P < 0.001; data not shown).
In general, in most samples, proportions of t4a n dt5
C 1 8 : 1a sw e l la so ft3,c9,c11 C18:3 were below the
Table 1 Daily intake of energy and dietary fatty acids estimated by food frequency questionnaires and regarding
calculated dairy fat intake (n = 41)
Total (n = 41) Dairy fat intake
< 40 g/d (n = 27)
Dairy fat intake
> 40 g/d (n = 14)
P
1
Reported daily dairy fat intake g/d 36.7 ± 16.5 27.1 ± 7.88 56.3 ± 11.8 ###
Kcal 2544 ± 595 2463 ± 561 2699 ± 649
Energy intake, MJ/d 10.6 ± 2.49 10.3 ± 2.35 11.3 ± 2.72
Carbohydrates, g/d (en%) 244 ± 60.9 (40.5 ± 5.60) 247 ± 57.7 237 ± 68.6
Protein, g/d (en%) 106 ± 35.4 (17.4 ± 3.16) 101 ± 32.3 115 ± 40.5
Fat, g/d (en%) 124 ± 33.4 (45.5 ± 4.74) 116 ± 30.1 140 ± 34.9 #
SFA, g/d (en%) 53.9 ± 14.1 (19.2 ± 2.94) 48.3 ± 11.5 64.8 ± 12.4 ###
MUFA, g/d (en%) 45.8 ± 13.5 (16.1 ± 2.07) 43.5 ± 12.1 50.3 ± 15.3
PUFA, g/d (en%) 16.9 ± 6.25 (5.90 ± 1.36) 17.1 ± 6.22 16.7 ± 6.54
n-3 PUFA, g/d 1.67 ± 0.54 1.50 ± 0.53 2.00 ± 0.38 ##
n-6 PUFA, g/d 10.2 ± 3.97 9.88 ± 3.64 10.8 ± 4.64
Short chain FA, g/d 2.11 ± 1.02 1.54 ± 0.60 3.20 ± 0.72 ###
Medium chain FA, g/d 1.88 ± 0.74 1.51 ± 0.56 2.58 ± 0.52 ###
Long chain FA, g/d 78.1 ± 25.8 68.7 ± 20.8 96.2 ± 25.5 ##
LC-PUFA, g/d 0.42 ± 0.26 0.41 ± 0.28 0.45 ± 0.21
n-3 LC-PUFA, g/d 0.32 ± 0.22 0.30 ± 0.24 0.34 ± 0.18
n-6 LC-PUFA, g/d 0.24 ± 0.11 0.23 ± 0.12 0.25 ± 0.09
C18:1 t11
2 0.37 ± 0.16 0.27 ± 0.08 0.56 ± 0.12 ###
Mean ± SD; SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids.
1 Means are significantly different between low and high dairy fat intake (t-Test): # P < 0.05; ## P < 0.01; ### P < 0.001.
2 Calculated with 1% t11 of dairy fat [21].
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C18:1 were the only trans isomers which were lower in
maternal than in fetal lipids (Table 3). [However, since
there was no pre-separation of cis C18:1 via Ag+-TLC
before GC analysis, an overestimation of t13/14 C18:1
due to co-elution with cis C18:1 isomers c6-8 could
have occurred [34]. It is also possible that c6-8 C18:1
are especially relevant in fetal lipids, however, no data
are available in the literature].
- Conjugated linoleic acids
The c9,t11 CLA was significantly higher in maternal
than in fetal lipids (Table 3). Moreover, positive correla-
tions of c9,t11 CLA between maternal and fetal lipids
were stronger for plasma than for erythrocytes (Table 3).
In Pmat and Pfet,e l e v a t e dc9,t11 CLA were seen com-
pared to t11, whilst both were equally distributed in the
respective erythrocyte lipids. In addition, maternal t11
in plasma and erythrocytes was positively correlated to
the respective fetal c9,t11 CLA (r = 0.51, r = 0.59; P <
0.001, respectively, data not shown).
- Polyunsaturated fatty acids
Quantities of AA, n-6, and DHA, n-3, were significantly
higher in Pfet and Efet than in the respective maternal
lipids. In contrast, proportions of linoleic acid (C18:2 n-6)
were higher in the maternal than in fetal lipids (Table 3).
- Correlation between trans fatty acids and polyunsaturated
fatty acids
Analysis of correlations between tFA and LC-PUFA
revealed a heterogeneous result. However, a significant
negative association was found in Pfet between t9 and n-
3 LC-PUFA (total, DPA n-3, DHA) while t11 was
negatively associated with n-6 LC-PUFA in Emat and Efet
(Table 4).
Furthermore, regarding correlations of maternal to
fetal fatty acids, t11 in maternal blood lipids was posi-
tively associated with fetal n-3 LC-PUFA, especially in
erythrocytes (Table 4(B)).
Association between dairy fat intake and fatty acid profile
of blood lipids (n = 41)
A high maternal intake of dairy fat (> 40 g/d; n = 14)
resulted in an elevated amount of milk specific fatty
a c i d ss u c ha sC 1 5 : 0 ,C 1 7 : 0a n dt11 in both maternal
lipid fractions (Pmat and Emat)c o m p a r e dt om o t h e r s
with lower dairy fat intake (n = 27; Table 5). In contrast,
in fetal lipids, the high maternal dairy fat intake was
only reflected by a higher c9,t11 CLA in plasma and ery-
throcytes, whereas t11 was not elevated. But, since t11
was elevated in maternal lipids, the t9/t11-index had
decreased, which was also shown in fetal lipids. In addi-
tion, due to a high dairy fat intake, n-3 LC-PUFA such
as EPA, DPA, and DHA were elevated in fetal lipids,
particularly in plasma (Table 5).
Data analysis regarding fatty acid correlation between
maternal and fetal lipids clearly showed that both t11
and c9,t11 CLA were positively correlated between Pmat
and Pfet in the case of low and high dairy fat intake (Fig-
ure 1). In contrast, no correlation was observed for t9
between maternal and fetal lipids, independently of
dairy fat intake (Figure 1). A high dairy fat intake did
not result in a negative correlation between t11 and t9
in all maternal and fetal blood lipids (data not shown).
Table 2 Maternal and infant characteristics (n = 55 mother-child pairs)
Infant sex: male, n (%) 32 (58.2)
Gestational age (wk) 39.5 ± 1.07
1
Birth weight (g) 3450 ± 476
1
Birth length (cm) 50.4 ± 2.50
1
Delivery method, n (%)
Spontaneous labour 31 (56.4)
Elective caesarean 20 (36.4)
Caesarean after failure to progress in labour 4 (7.30)
Parity at entry, n (%)
0 34 (61.8)
1 11 (20.0)
≥2 6 (10.1)
Maternal age (years) 29.2 ± 5.28
1
Maternal BMI before pregnancy (kg/m
2) 22.3 ± 2.6
1
Maternal BMI at birth (kg/m
2) 27.8 ± 2.84
1
Maternal atopy, n (%) 16 (29.1)
Tobacco exposition (maternal and/or paternal smoking) in pregnancy, n (%) 18 (32.7)
All blood donors.
1 mean ± SD.
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The quantities of fatty acids in maternal and, especially,
in fetal blood are under the influence of various factors.
Since tFA are not synthesised in human tissue, all tFA
with isolated double bonds present in fetal blood lipids
c a no n l yb ed u et oat r a n s p l acental transfer and must
originate from maternal diet. Herein, we investigated the
fatty acid composition of plasma and erythrocytes in
mother-child pairs at birth, focussing on total tFA and
individual trans C18:1 such as t9a n dt11 with special
regard to dairy fat intake.
-Total trans fatty acids in maternal and fetal blood lipids
In the present study, total tFA concentrations in mater-
nal and fetal lipids were about 0.5 to 0.8% of FAME,
with generally higher levels in maternal and plasma
lipids compared to fetal and erythrocyte lipids, respec-
tively. In several recently published European studies,
Table 3 Fatty acids in maternal and fetal plasma and erythrocytes (n = 55)
Plasma Erythrocytes
Mean ± SD
1
(% of total FAME)
Correlation
2
maternal vs. fetal
Mean ± SD
1
(% of total FAME)
Correlation
2
maternal vs. fetal
maternal fetal P r P maternal fetal P r P
C14:0 1.21 ± 0.40 1.12 ± 0.34 0.26 0.83 ± 0.51 0.63 ± 0.30 * -0.06
C15:0 0.27 ± 0.06 0.20 ± 0.05 0.31 ￿ 0.25 ± 0.07 0.17 ± 0.03 0.27 ￿
C16:0 30.2 ± 2.31 29.8 ± 1.40 0.15 31.8 ± 2.86 34.9 ± 1.62 *** 0.18
C17:0 0.24 ± 0.04 0.26 ± 0.05 0.24 0.35 ± 0.12 0.29 ± 0.04 0.30 ￿
C18:0 5.59 ± 0.78 9.99 ± 0.81 *** 0.12 15.1 ± 1.51 15.3 ± 1.18 0.01
C18:1 n-9 23.9 ± 2.45 18.5 ± 2.01 *** 0.35 ￿￿ 17.5 ± 1.10 13.8 ± 1.01 *** 0.16
C18:1 n-7 2.05 ± 0.26 3.50 ± 0.46 *** 0.45 ￿￿￿ 1.51 ± 0.16 2.73 ± 0.31 *** 0.42 ￿￿￿
C18:2 n-6 23.5 ± 3.41 10.9 ± 1.59 *** 0.35 ￿￿ 10.5 ± 1.08 4.55 ± 0.52 *** 0.54 ￿￿￿
C18:3 n-6 0.16 ± 0.06 0.30 ± 0.06 *** 0.32 ￿ 0.05 ± 0.03 0.05 ± 0.03 -0.20
C20:3 n-6 1.55 ± 0.32 3.31 ± 0.59 *** 0.29 ￿ 1.92 ± 0.43 3.22 ± 0.50 *** 0.35 ￿￿
C20:4 n-6 AA 3.83 ± 0.89 11.7 ± 1.94 *** 0.29 ￿ 10.6 ± 2.47 15.0 ± 1.42 *** 0.24
C22:4 n-6 0.02 ± 0.02 0.03 ± 0.06 -0.05 0.03 ± 0.03 0.03 ± 0.06 0.07
C22:5 n-6 0.19 ± 0.08 0.53 ± 0.16 *** 0.66 ￿￿￿ 0.56 ± 0.23 1.08 ± 0.24 *** 0.60 ￿￿
C18:3 n-3 0.41 ± 0.11 0.12 ± 0.04 *** 0.37 ￿￿ 0.15 ± 0.04 0.03 ± 0.03 *** 0.04
C20:5 n-3 EPA 0.24 ± 0.10 0.25 ± 0.14 0.15 0.33 ± 0.16 0.13 ± 0.06 *** 0.32 ￿
C22:5 n-3 0.16 ± 0.04 0.21 ± 0.09 *** 0.17 1.29 ± 0.49 0.41 ± 0.12 *** -0.02
C22:6 n-3 DHA 1.21 ± 0.35 3.00 ± 0.83 *** 0.07 3.40 ± 1.45 4.24 ± 0.98 *** 0.02
SFA 67.8 ± 4.77 71.2 ± 3.09 *** 0.14 80.2 ± 6.71 86.3 ± 3.24 *** 0.05
MUFA 29.2 ± 2.93 26.1 ± 2.97 *** 0.30 ￿ 19.6 ± 1.25 17.2 ± 1.11 *** 0.16
n-6 LC-PUFA 5.59 ± 1.08 15.6 ± 2.14 *** 0.25 13.1 ± 2.71 19.4 ± 1.52 *** 0.14
n-3 LC-PUFA 1.61 ± 0.46 3.46 ± 0.99 *** 0.10 5.02 ± 2.04 4.79 ± 1.12 0.00
C18:1 t6/7/8 0.03 ± 0.01 0.02 ± 0.01 *** 0.11 0.07 ± 0.05 0.07 ± 0.09 0.05
C18:1 t9 0.12 ± 0.02 0.10 ± 0.03 *** 0.24 0.15 ± 0.03 0.12 ± 0.12 -0.06
C18:1 t10 0.05 ± 0.02 0.03 ± 0.01 *** 0.19 0.07 ± 0.02 0.05 ± 0.08 -0.12
C18:1 t11 0.10 ± 0.05 0.05 ± 0.03 *** 0.51 ￿￿￿ 0.14 ± 0.04 0.06 ± 0.05 *** 0.13
C18:1 t12 0.07 ± 0.02 0.03 ± 0.01 *** 0.29 ￿ 0.11 ± 0.03 0.04 ± 0.04 *** 0.11
C18:1 t13/14 0.05 ± 0.02 0.17 ± 0.09 *** 0.19 0.08 ± 0.03 0.20 ± 0.04 *** 0.23
C18:1 t15 0.03 ± 0.01 0.02 ± 0.01 ** 0.18 0.07 ± 0.02 0.03 ± 0.03 *** 0.16
C18:1 t16 0.05 ± 0.02 0.03 ± 0.01 *** 0.37 ￿￿ 0.06 ± 0.02 0.03 ± 0.01 *** 0.09
C18:2 t9,12 0.02 ± 0.02 0.03 ± 0.02 *** -0.24 0.02 ± 0.02 0.02 ± 0.01 0.09
Total tFA 0.59 ± 0.12 0.52 ± 0.17 ** 0.36 ￿￿ 0.82 ± 0.15 0.64 ± 0.45 ** 0.07
t9/t11-index 1.30 ± 0.53 2.17 ± 0.86 *** 0.39 ￿￿￿ 1.11 ± 0.33 2.13 ± 0.64 *** 0.36 ￿￿
c9,t11 CLA 0.20 ± 0.07 0.14 ± 0.04 *** 0.84 ￿￿￿ 0.12 ± 0.04 0.08 ± 0.04 *** 0.32 ￿
FAME, fatty acid methyl esters; SFA, saturated fatty acids (sum of C12:0, C14:0, C15:0, C16:0, C17:0 and C18:0); MUFA, monounsaturated fatty acids (sum of the cis
isomers of C16:1, C18:1 n-9 and C18:1 n-7); n-3 and n-6 LC-PUFA, omega-3 and omega-6 long chain polyunsaturated fatty acids (sum of C20:5 n-3, C22:5 n-3,
C22:6 n-3 and C20:3 n-6, C20:4 n-6, C22:4 n-6, C22:5 n-6, respectively); total tFA, total trans fatty acids (sum of C18:1 t4, t5, t6/7/8, t9, t10, t11, t12, t13/14, t15 and
t16 as well as C18:2 t9,12, C18:3 t3,c9,c11 and C18:3 c8,t10,t12).
1 Means are significantly different between maternal and fetal lipids (paired t-Test): *P < 0.05; ** P < 0.01; *** P < 0.001.
2 r = Pearson correlation coefficient between the respective fatty acid in maternal and fetal plasma or erythrocyte lipids: ￿ P < 0.05; ￿￿ P < 0.01; ￿￿￿ P < 0.001.
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and plasma lipids range from 0.08% to 0.45% in phos-
pholipids and up to 2.74% in the other lipid fractions,
however, with higher tFA values in maternal than in
fetal lipids [13,19,20,35]. Nevertheless, comparison of
data for total tFA is difficult since percentages of single
fatty acids may vary according to the analysed plasma
fractions (phospholipids vs.t o t a ll i p i d s ;[ 3 6 ] )a n dt h e
applied method of analysis (GC-column, varying num-
bers of analysed/identified fatty acids, integration para-
meters, management of un-identified peaks).
- trans fatty acid intake
Following a number of accounts regarding adverse
health effects [6,37], the tFA, content in foods has con-
tinuously decreased over the last decades [21,38]. Recent
reports estimate the mean dietary tFA intake in Ger-
many at 2.3 g/d for men (0.8 en%) and 1.6 g/d for
women (0.74 en%; [39]). Since tFA content varies
strongly within food categories [21], the exact intake of
tFA is difficult to calculate. Furthermore, the distribu-
tion of individual tFA isomers varies according to their
origin. In dairy fat, t11 is generally the major t18:1 con-
taining about 1.0 to 2.0% of FAME [21,40]. Thus, the
present maternal mean values for low and high dairy fat
intake were approximately 27.1 and 56.3 g/d, which
were estimated as corresponding to about 0.3 to 0.6 g
t11/d, respectively (Table 2). This assessment is in line
with recent data regarding the average t11 intake [39].
In contrast, the t9 intake in the age group 30 ± 5 years
of the present study population was found to be about
twice as high as the t11 intake [39] resulting in a mean
dietary t9/t11-index of about 2.
-Individual trans fatty acids in blood lipids
Hardly any data are available in the literature concern-
ing individual trans C18:1 such as t11 and t9i nm a t e r -
nal and/or fetal blood lipids. The present proportions of
t9a n dt11 were similar in maternal blood lipids (Pmat
0.12 vs.0 . 1 0 ) .W h e r e a st9 in fetal blood lipids tended to
be lower compared to maternal lipids, t11 was only half
the value of maternal t11 (Pmat 0.10 vs.P fet 0.05; Table
3). This resulted in fetal t9/t11-indices being twice as
high as maternal indices (Table 3, 5).
A general positive correlation of t11, but not of t9
was seen between maternal and fetal plasma (Table 3
Figure 1). However, fetal t11 was about the half that of
t9 (Table 3). This low value could indicate differences
in materno-fetal transfer as well as metabolism (oxida-
tion, conversion, incorporation) of both individual trans
isomers t9a n dt11, as has been observed in rat hepato-
cytes [41,42].
Table 4 Correlation (r) between tFA and LC-PUFAs in maternal and fetal plasma and erythrocytes (n = 55)
n-6 n-3 n-6 LC-PUFA n-3 LC-PUFA
C20:4 n-6
AA
C22:5 n-6
DPA
C20:5 n-3
EPA
C22:5 n-3
DPA
C22:6 n-3
DHA
A) Between different fatty acids within the same blood fraction (e.g., Pmat to Pmat)
C18:1 t9P mat -0.33 ￿ -0.28 ￿ -0.11 -0.18 -0.28 ￿ -0.33 ￿ -0.26
Pfet -0.21 -0.07 -0.08 -0.40 ￿￿ -0.36 ￿￿ -0.24 -0.35 ￿￿
Emat 0.13 -0.18 -0.05 0.18 0.03 0.13 0.06
Efet -0.26 0.03 -0.06 0.02 0.01 -0.26 0.00
C18:1 t11 Pmat -0.08 0.05 0.25 -0.19 0.06 -0.12 0.11
Pfet -0.24 0.02 0.07 0.06 -0.01 -0.22 0.01
Emat -0.32 ￿ -0.29 ￿ 0.07 -0.06 -0.13 -0.36 ￿￿ -0.10
Efet -0.31 ￿ -0.01 0.04 0.14 0.10 -0.30 ￿ 0.11
total tFA Pmat -0.25 0.04 0.16 -0.24 -0.07 -0.22 -0.01
Pfet -0.22 -0.03 0.06 -0.04 -0.09 -0.21 -0.07
Emat -0.30 ￿ -0.31 ￿ -0.02 -0.05 -0.16 -0.32 ￿ -0.13
Efet -0.30 ￿ 0.01 -0.07 0.00 -0.02 -0.29 ￿ -0.02
B) Between different maternal and fetal fatty acids within the respective blood fraction (e.g., Pmat to Pfet)
C18:1 t9P mat ® Pfet -0.14 -0.14 0.00 -0.05 -0.15 -0.17 -0.13
C18:1 t11 -0.19 0.05 0.10 0.21 0.08 -0.20 0.10
total tFA -0.24 -0.05 0.09 0.08 -0.08 -0.21 -0.05
C18:1 t9E mat ® Efet 0.15 -0.11 -0.19 -0.12 -0.04 0.08 -0.06
C18:1 t11 -0.09 -0.16 0.46 ￿￿ 0.41 ￿￿ 0.26 -0.12 0.29 ￿
total tFA -0.01 -0.17 0.29 ￿ 0.24 0.20 -0.03 0.21
Pearson correlation coefficient (r); ￿ P < 0.05; ￿￿ P < 0.01.
A) e.g. t9P mat to AA Pmat.
B) e.g. t9P mat to AA Pfet.
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Dairy fat contains CLA (mainly c9,t11 CLA), which is
formed by Δ9-desaturation of t11 [23]. In dairy fat and
human breast milk, t11 was generally higher compared to
c9,t1 1C L A ,w h i l s tt h er a t i or a n g e df r o m4 : 1t o2 : 1
[31,43,44].
In the present study, irrespective of dairy fat intake, t11
was lower compared to c9,t11 CLA in lipids of maternal
and fetal plasma (1:2; Table 3) probably reflecting the con-
version of t11 to c9,t11 CLA by Δ9-desaturase and/or its
preferred oxidation [22]. In contrast, the ratio of t11 to c9,
t11 CLA in erythrocyte lipids was about 1:1, since mater-
nal and fetal c9,t11 CLA was lower compared to their
levels in plasma, in accordance with data described by
Mueller et al [17]. This aspect may be caused by a higher
incorporation of CLA into neutral lipids than into phos-
pholipids, the major lipid fraction in erythrocytes [45].
Further, our results confirmed that maternal c9,t11 CLA
(dietary and of endogenous origin) was positively corre-
lated to fetal c9,t11 CLA (Table 3) [44].
Table 5 Differences of selected fatty acids in maternal and fetal plasma and erythrocytes regarding high and low
dairy fat intake
Plasma Erythrocytes
Dairy fat intake maternal
1 fetal
1 P
2 maternal
1 fetal
1 P
2
SFA C15:0 high 0.30 ± 0.07 # 0.21 ± 0.04 ‡ *** 0.31 ± 0.09 # 0.18 ± 0.02 ***
low 0.26 ± 0.05 0.19 ± 0.04 *** 0.24 ± 0.05 0.16 ± 0.03 ***
C17:0 high 0.26 ± 0.05 # 0.26 ± 0.03 0.38 ± 0.08 0.30 ± 0.04 ***
low 0.23 ± 0.04 0.25 ± 0.05 0.36 ± 0.17 0.29 ± 0.04 *
n-6 C18:2 n-6 high 22.7 ± 2.89 # 10.8 ± 1.09 *** 9.77 ± 0.89 4.40 ± 0.45 ***
low 23.8 ± 3.58 10.8 ± 1.45 *** 10.7 ± 1.08 4.56 ± 0.49 ***
C20:4 n-6
AA
high 4.15 ± 0.99 11.6 ± 1.63 *** 9.90 ± 2.81 ‡ 15.3 ± 1.34 ***
low 3.64 ± 0.86 11.6 ± 2.21 *** 10.8 ± 2.41 14.9 ± 1.62 ***
n-6 LC-PUFA high 5.90 ± 1.22 15.4 ± 1.83 *** 12.2 ± 3.15 19.7 ± 1.46 ***
low 5.38 ± 1.05 15.5 ± 2.49 *** 13.3 ± 2.63 19.2 ± 1.66 ***
n-3 C20:5 n-3
EPA
high 0.30 ± 0.12 0.29 ± 0.10 ## 0.34 ± 0.16 # 0.17 ± 0.06 ***
low 0.21 ± 0.08 0.24 ± 0.17 0.33 ± 0.14 0.12 ± 0.04 ***
C22:5 n-3
DPA
high 0.17 ± 0.06 0.24 ± 0.05 ## ** 1.21 ± 0.48 0.47 ± 0.10 # ***
low 0.16 ± 0.05 0.19 ± 0.07 * 1.30 ± 0.44 0.38 ± 0.08 ***
C22:6 n-3
DHA
high 1.34 ± 0.32 3.17 ± 0.72 ‡ *** 3.21 ± 1.64 ‡ 4.61 ± 0.84 **
low 1.16 ± 0.38 2.86 ± 0.72 *** 3.55 ± 1.41 4.11 ± 0.96 §
n-3 LC-PUFA high 1.81 ± 0.44 3.70 ± 0.84 # *** 4.76 ± 2.25 ‡ 5.25 ± 0.97
low 1.52 ± 0.48 3.29 ± 0.83 *** 5.17 ± 1.92 4.61 ± 1.05
tFA C18:1 t9 high 0.12 ± 0.02 0.09 ± 0.01 *** 0.15 ± 0.03 0.10 ± 0.02 ***
low 0.12 ± 0.03 0.10 ± 0.03 ** 0.15 ± 0.03 0.15 ± 0.17
C18:1 t10 high 0.05 ± 0.01 0.03 ± 0.01 *** 0.07 ± 0.02 0.04 ± 0.02 ***
low 0.05 ± 0.02 0.02 ± 0.01 *** 0.07 ± 0.02 0.07 ± 0.12
C18:1 t11 high 0.12 ± 0.04 # 0.05 ± 0.02 *** 0.17 ± 0.04 # 0.06 ± 0.03 ***
low 0.09 ± 0.03 0.05 ± 0.02 *** 0.13 ± 0.02 0.07 ± 0.06 ***
C18:1 t12 high 0.08 ± 0.02 ## 0.03 ± 0.01 *** 0.13 ± 0.03 0.04 ± 0.01 ***
low 0.07 ± 0.02 0.03 ± 0.01 *** 0.10 ± 0.02 0.05 ± 0.06 ***
total tFA high 0.62 ± 0.09 # 0.49 ± 0.10 *** 0.92 ± 0.19 # 0.57 ± 0.13 ***
low 0.56 ± 0.10 0.50 ± 0.15 0.78 ± 0.10 0.74 ± 0.64
t9/t11- high 1.07 ± 0.31 # 1.81 ± 0.35 *** 0.91 ± 0.28 # 1.74 ± 0.58 # ***
index low 1.42 ± 0.48 2.32 ± 0.83 *** 1.18 ± 0.29 2.35 ± 0.70 ***
CLA c9,t11 CLA high 0.25 ± 0.06 ## 0.17 ± 0.04 ## *** 0.15 ± 0.05 # 0.11 ± 0.06 ‡
low 0.18 ± 0.04 0.12 ± 0.03 *** 0.10 ± 0.03 0.07 ± 0.02 ***
1 Portions of the respective fatty acid in % of total FAME as mean ± SD of high dairy fat intake (> 40 g/d, upper values; n = 14) and low dairy fat intake (< 40 g/
d, lower values; n = 27); means are different between both groups (unpaired t-Test): ‡ P < 0.1; # P < 0.05; ## P < 0.01.
2 Means are different between maternal and fetal lipids in the respective group of dairy fat intake (paired t-Test): § P < 0.1 * P < 0.05; ** P < 0.01; *** P < 0.001.
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Figure 1 Correlation of the individual tFA, the t9/t11-index, and c9,t11 CLA. Correlation between the respective fatty acid in maternal and
fetal (A) plasma (filled signs) and (B) erythrocytes (open signs) in groups of low (< 40 g/d, n = 27; grey) and high (> 40 g/d, n = 14; black) dairy
fat intake. Correlations irrespective of dairy fat intake are listed in Table 3.
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acids in blood lipids
The present results clearly showed an association
between ruminant fat consumption and fatty acid distri-
bution of human lipids. A high dairy fat intake in
mothers (> 40 g/d) resulted in increased c9,t11 CLA and
total tFA, especially t11 in blood lipids. Moreover, the
raised t11 concentrations resulted in a decreased mater-
nal t9/t11-index (Table 5).
In breast milk of mothers with comparably high con-
sumption of dairy fat (> 40 g/d), elevated t11 and c9,t11
CLA and a decreased t9/t11-index were also observed
[30,44]. The increase in the milk specific fatty acids
C15:0 and C17:0 in maternal blood also confirmed the
high dairy fat intake in the present study (Table 5). Simi-
lar results were obtained in breast milk in a former study
[44]. Interestingly, due to a maternal high dairy fat intake,
only c9,t11 CLA and not t11 was elevated in the corre-
sponding fetal blood lipids (Table 5).
H o w e v e r ,t h e r ew a sap o s i t i v ec o r r e l a t i o no ft11 in
plasma between mother and child (not in erythrocytes,
Figure 1). The t9 levels did not significantly differ and
there was no correlation between maternal and fetal
lipids on comparing a high and low dairy fat diet (Table
5). Although the results point to differences between t9
and t11 regarding metabolism and/or transfer, respective
data are not yet available for humans.
- Trans fatty acids and long chain-PUFA in maternal and
fetal blood lipids
The composition of maternal dietary fat and body fat
depot [14,35] strongly accounts for the fatty acid composi-
tion in fetal tissue. However, the increased amounts of n-6
LC-PUFA (AA, DPA) and n-3 LC-PUFA (DPA, DHA) in
fetal plasma and erythrocytes compared to maternal lipids
observed in the present and former studies is physiologi-
cally consistent and attributed to the special requirements
of the fetus (Table 3) [46,47]. Further, a wide range of fatty
acid transporters and binding proteins in the placenta
determines the enrichment of these LC-PUFA [11,12].
Several publications show an inverse association
between total tFA and both n-6 (e.g. AA) as well as n-3
LC-PUFA (e.g. DHA) in blood lipids. However, since
these data only deal with either maternal or fetal blood
lipids and not with their interaction as well as different
lipid fractions were used, comparison is difficult [18,20].
In the present study, total tFA were also inversely asso-
ciated with the sum of n-6, but not n-3 LC-PUFA
within the same blood fraction (partly significant; Table
4(A)). Regarding n-3 LC-PUFA in fetal plasma, a nega-
tive correlation was only found for t9, but not for t11
(Table 4(A). This result might be of relevance, since n-3
have been shown to extend anti-inflammatory effects
[5].
Concerning the relationship between maternal and
fetal lipids, the current study data showed a positive cor-
relation of t11 to n-3 LC-PUFA, however, the result was
only significant in erythrocytes (Table 4(B)). This effect
could be associated with a higher dairy fat intake, since
n-3 LC-PUFA (EPA, DPA, DHA) were significantly ele-
vated in the respective fetal plasma (Table 5). Some stu-
dies have revealed the ability of tFA to inhibit several
enzymes involved in LC-PUFA synthesis but without
distinguishing between industrial and ruminant tFA
[48,49]. However, there is little data regarding the
impact of tFA on placental fatty acid transporters show-
ing that t9 may inhibit binding of PUFA at placental
membranes [50].
Differences between t9 and t11 indicated herein might
be the result of isomer-specific influences on transcrip-
tion factors (such as PPARs) involved in the expression
of placental transport proteins [51,52]. From cellular
and animal models, there is evidence that t9 inhibits
[53] and t11 activates [54] PPAR expression. Thus, dif-
ferences in PPAR activation by t9a n dt11 could inter-
fere with the cellular uptake of LC-PUFA into the
placenta [55,56].
Conclusions
We analysed for the first time individual isomers of
trans C18:1 in blood lipids of mother-child pairs at
birth and found differences between t9 and t11.
In fetal lipids, t11 accumulation was only half that of
t9, probably due to t11 conversion to c9,t11 CLA. In
general, total tFA, including t9a n dt11, were higher in
maternal than in fetal lipids. The present results also
demonstrated that maternal high dairy fat intake led to
increased t11 and c9,t11 CLA in the blood lipids. How-
ever, t11 was not increased in the respective fetal lipids.
In addition, the essential n-3 LC-PUFA were elevated in
fetal blood lipids.
Thus, tFA have to be distinguished according to their
origin (ruminant or industrial) to separately investigate
their possible influence on fetal development and
human health.
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